Literature DB >> 15759027

Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension.

J N Lubianca1, L B Moreira, M Gus, F D Fuchs.   

Abstract

The association of combined oral contraceptives (OC) with higher blood pressure (BP) may be attenuated with pills with smaller doses of oestrogen. The effect of stopping OC on BP of patients with hypertension was not described to date. In a cohort study of patients with hypertension, we identified 72 women using OC among 2112 patients seen from 1989 to 2002. Stopping hormonal contraception was recommended to all. The main outcome measurement was BP change in women who stopped (n=44) and who did not stop (n=28) OC, adjusting for baseline BP and age. Odds ratio for having a reduction of at least 20 mmHg in systolic blood pressure (SBP) or 10 mmHg in diastolic blood pressure (DBP), adjusting for age, change in weight and prescription of BP-lowering drugs, were calculated. The mean follow-up time was 6.6+/-7.5 months. Participants who stopped and did not stop OC had similar baseline characteristics. The deltas of SBP (adjusted) were 15.1+/-2.6 mmHg in patients who stopped and 2.8+/-3.2 mmHg in patients who did not stop OC (P=0.004). The corresponding values for DBP were 10.4+/-1.8 and 2.7+/-2.2 mmHg (P=0.008), respectively. The odds ratio (adjusted) for having a decrease of at least 20 mmHg in SBP or 10 mmHg in DBP was 0.28 (95% CI 0.08-0.90) in patients who stopped OC. Stopping OC is an effective antihypertensive intervention in a clinical setting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15759027     DOI: 10.1038/sj.jhh.1001841

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  11 in total

1.  The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate.

Authors:  Jarir Atthobari; Ron T Gansevoort; Sipke T Visser; Paul E de Jong; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

Review 2.  Recognizing and improving health care disparities in the prevention of cardiovascular disease in women.

Authors:  Jennifer L Jarvie; Joanne M Foody
Journal:  Curr Cardiol Rep       Date:  2010-11       Impact factor: 2.931

Review 3.  Estrogen and hypertension.

Authors:  Muhammad S Ashraf; Wanpen Vongpatanasin
Journal:  Curr Hypertens Rep       Date:  2006-10       Impact factor: 5.369

Review 4.  Dyslipidemia and cardiovascular disease in women.

Authors:  Renata Cífková; Alena Krajčoviechová
Journal:  Curr Cardiol Rep       Date:  2015-07       Impact factor: 2.931

5.  2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Authors:  Tzung-Dau Wang; Chern-En Chiang; Ting-Hsing Chao; Hao-Min Cheng; Yen-Wen Wu; Yih-Jer Wu; Yen-Hung Lin; Michael Yu-Chih Chen; Kwo-Chang Ueng; Wei-Ting Chang; Ying-Hsiang Lee; Yu-Chen Wang; Pao-Hsien Chu; Tzu-Fan Chao; Hsien-Li Kao; Charles Jia-Yin Hou; Tsung-Hsien Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

6.  Elevation of Oxidized Lipoprotein of Low Density in Users of Combined Oral Contraceptives.

Authors:  Alan Carlos Nery Dos Santos; Jefferson Petto; Diego Passos Diogo; Candice Rocha Seixas; Lunara Horn de Souza; Wagner Santos Araújo; Ana Marice Teixeira Ladeia
Journal:  Arq Bras Cardiol       Date:  2018-10-11       Impact factor: 2.000

7.  Factors associated with prognostic or treatment outcomes in HIV/AIDS patients with and without hypertension in Eswatini.

Authors:  Sabelo Bonginkosi Dlamini; Hans-Uwe Dahms; Ming-Tsang Wu
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

Review 8.  Hypertension in Women Across the Lifespan.

Authors:  Lama Ghazi; Natalie A Bello
Journal:  Curr Atheroscler Rep       Date:  2021-06-19       Impact factor: 5.967

9.  Effect of hormonal contraceptives on lipid profile and the risk indices for cardiovascular disease in a Ghanaian community.

Authors:  George A Asare; Sheila Santa; Robert A Ngala; Bernice Asiedu; Daniel Afriyie; Albert Gb Amoah
Journal:  Int J Womens Health       Date:  2014-06-03

Review 10.  Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits.

Authors:  Anderson Sanches de Melo; Rosana Maria Dos Reis; Rui Alberto Ferriani; Carolina Sales Vieira
Journal:  Open Access J Contracept       Date:  2017-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.